Vivo Capital, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Vivo Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$0.96 - $1.74 $6.19 Million - $11.2 Million	-6,451,612 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$0.76 - $1.47 $3.67 Million - $7.1 Million	-4,827,711 Reduced 42.8%	6,451,612 $8.77 Million
Q1 2020 May 15, 2020	BUY	$0.6 - $2.31 $6.77 Million - $26.1 Million	11,279,323 New	11,279,323 $6.77 Million
Q3 2019 Nov 13, 2019	SELL	$0.59 - $0.9 $4.02 Million - $6.14 Million	-6,818,181 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$0.6 - $1.41 $4.09 Million - $9.61 Million	6,818,181 New	6,818,181 $7.43 Million

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $117M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Vivo Capital, LLC with notifications on news.